IOmx

IOmx
IOmx
iOmx Therapeutics focuses on the development of first-in-class cancer therapeutics addressing novel immune checkpoint modulators on tumor cells. By systematically screening human tumor cells, the Company has already identified a number of novel targets and analyzed their mode of action.
Germany
health, cancer, health tech
2016
http://iomx.de
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as IOmx? We’re happy to assist you with our Startup Sourcing service.